Ibrutinib-Induced Uveitis: A Case of Rapid Ocular Toxicity in Mantle Cell Lymphoma

被引：0
|
作者：
Ramachandran, Sai Prasad [1 ]
Rayapureddi, Karthik [1 ]
Kriplani, Kushal [2 ]
Khurana, Harshit [1 ]
机构：
[1] Armed Forces Med Coll, Pune, Maharashtra, India
[2] Vardhaman Mahavir Med Coll & Safdurjung Hosp, Delhi, India
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
MCL; ibrutinib; uveitis; mantle cell lymphoma;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MCL-640
引用
收藏
页码：S518 / S518
页数：1
相关论文
共 50 条
  • [31] Cell-Intrinsic Determinants of Ibrutinib-Induced Apoptosis in Chronic Lymphocytic Leukemia
    Amin, Nisar A.
    Balasubramanian, Sriram
    Saiya-Cork, Kamlai
    Shedden, Kerby
    Hu, Nan
    Malek, Sami N.
    CLINICAL CANCER RESEARCH, 2017, 23 (04) : 1049 - 1059
  • [32] IBRUTINIB FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA AND MANTLE CELL LYMPHOMA
    McDermott, J.
    Jimeno, A.
    DRUGS OF TODAY, 2014, 50 (04) : 291 - 300
  • [33] A Case of Ileocolic Intussusception Induced by Mantle Cell Lymphoma
    Ryu, Kum Hei
    Shim, Ki-Nam
    Song, Hyun Joo
    Na, Yoon Ju
    Baik, Su Jung
    Yoon, Su Jin
    Jung, Hae-Sun
    Yeom, Hye Jung
    Jung, Sung-Ae
    Kim, Tae Hun
    Yoo, Kwon
    Cho, Mm-Sun
    INTESTINAL RESEARCH, 2006, 4 (01) : 61 - 63
  • [34] Ibrutinib: a strong candidate for the future of mantle cell lymphoma treatment
    Zhang, Liang
    Newberry, Kate J.
    Wang, Michael
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2013, 9 (06) : 495 - 497
  • [35] IBRUTINIB PLUS PALBOCICLIB HAS EFFICACY IN MANTLE CELL LYMPHOMA
    不详
    CANCER DISCOVERY, 2019, 9 (03) : 318 - 318
  • [36] Molecular Pathways Associated with Ibrutinib Resistance in Mantle Cell Lymphoma
    Zhang, Liang
    Nomie, Krystle
    Zhang, Shaojun
    Liu, Yang
    Guo, Hui
    Huang, Shengjian
    Wang, Jeffrey
    Lopez, Elyse
    Zhang, Hui
    Lorence, Elizabeth A.
    Merolle, Maria
    Balaji, Swathi
    Ahmed, Makhdum
    Jiang, Changying
    Wang, Linghua
    Wang, Michael
    BLOOD, 2017, 130
  • [37] Pirtobrutinib Overcomes Ibrutinib and Venetoclax Resistance in Mantle Cell Lymphoma
    Liu, Yang
    Jiang, Changying
    Yan, Fangfang
    McIntos, Joseph
    Jordan, Alexa A.
    Li, Yijing
    Che, Yuxuan
    Cai, Qingsong
    Wang, Wei
    Nie, Lei
    Wang, Michael
    BLOOD, 2021, 138
  • [38] Ibrutinib in Mantle Cell Lymphoma Patients: Analysis of the Czech Lymphoma Study Group
    Obr, Ales
    Klener, Pavel, Jr.
    Janikova, Andrea
    Mocikova, Heidi
    Belada, David
    Salek, David
    Jirkuvova, Andrea
    Papajik, Tomas
    Trneny, Marek
    BLOOD, 2021, 138
  • [39] Bilateral Intraocular Involvement of Recurrent Mantle Cell Lymphoma with Remission of Pseudo-Uveitis and Secondary Glaucoma After Switching Treatment to Ibrutinib: A Case Report
    Takahashi, Tatsuhiro
    Matsuo, Masato
    Mochizuki, Kiyofumi
    Sakaguchi, Hirokazu
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2024,
  • [40] Ibrutinib in refractory mantle cell lymphoma or relapsed data update
    Paillassa, Jerome
    HEMATOLOGIE, 2015, 21 (05): : 257 - 259
12345